Search

Search Results
Results 7291 - 7300 of 8359 for allergy
  • DBL Desferrioxamine Mesylate
    Drug - 19 Jan 2023
    Consumer Medicine Information (CMI) about DBL Desferrioxamine Mesylate (desferrioxamine mesilate) intended for persons living in Australia.
  • Salpraz Heartburn Relief (reformulation 2)
    Drug - 5 Jan 2023
    Consumer Medicine Information (CMI) about Salpraz Heartburn Relief (reformulation 2) (Pantoprazole enteric coated tablets) intended for persons living in Australia.
  • Adesan
    Drug - 19 Dec 2022
    Consumer Medicine Information (CMI) about Adesan (candesartan cilexetil) intended for persons living in Australia.
  • Pariet 10
    Drug - 12 Dec 2022
    Consumer Medicine Information (CMI) about Pariet 10 (Rabeprazole sodium) intended for persons living in Australia.
  • Ondansetron Viatris
    Drug - 6 Dec 2022
    Consumer Medicine Information (CMI) about Ondansetron Viatris (ondansetron hydrochloride dihydrate) intended for persons living in Australia.
  • Pariet
    Drug - 2 Dec 2022
    Consumer Medicine Information (CMI) about Pariet (Rabeprazole sodium) intended for persons living in Australia.
  • Edronax
    Drug - 25 Nov 2022
    Consumer Medicine Information (CMI) about Edronax (Reboxetine mesilate) intended for persons living in Australia.
  • Osteovan
    Drug - 15 Nov 2022
    Consumer Medicine Information (CMI) about Osteovan (Zoledronic acid) intended for persons living in Australia.
  • Invega Sustenna
    Drug - 6 Nov 2022
    Consumer Medicine Information (CMI) about Invega Sustenna (Paliperidone palmitate) intended for persons living in Australia.
  • Entecavir Viatris
    Drug - 6 Nov 2022
    Consumer Medicine Information (CMI) about Entecavir Viatris (Entecavir) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback